Association Between Diabetes Complications and Leukocyte Counts in Iranian Patients

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2012 Feb 16

PMID 22334791

Citations 28

Authors

Sedigheh Moradi

Scott Reza Jafarian Kerman

Farzaneh Rohani

Fereshteh Salari

Affiliations

Soon will be listed here.

Abstract

Background: The long term complications of diabetes can be fatal. They are also renowned for being an economic burden. Previous studies have demonstrated a relationship between inflammatory markers and complications of diabetes. The objective of this study was to evaluate the relationship between leukocyte counts and these complications.

Methods: The study included 184 patients diagnosed with type 2 diabetes. The study was carried out in Iran during 2007 and 2008. Data collected on the subjects were as follows: age, gender, weight, height, blood pressure, smoking history, lipid profile including low density lipoprotein (LDL), high density lipoprotein (HDL), total cholesterol, triglycerides, and leukocyte count, albuminuria, and retinopathy. Furthermore, information on cardiac history for 100 patients was collected. The subjects were split into two groups according to their leukocyte levels: low (≤7000/mm(3)) and high (>7000/mm(3)); and then analyzed by Student's t-test or Mann-Whitney U-test as appropriate.

Results: The average leukocyte count in these patients was 7594 ± 1965/mm(3). Leukocyte count was significantly different in patients with and without retinopathy and albuminuria (P < 0.0001). According to this analysis, a leukocyte count of 6750/mm(3) with a sensitivity of 80.2% and a specificity of 56.4%, and a count of 7550/mm(3) with a sensitivity of 63.2% and a specificity of 74.6% indicated at least one diabetes complication.

Conclusion: An elevated leukocyte count even within the normal range was associated with chronic complications in type 2 diabetes.

Citing Articles

Red blood cell count and cystatin C as the specific biomarkers for diabetic retinopathy from diabetes mellitus: a case-control study.

Li Z, Li J, Zhong J, Qu C, Du M, Tian H Sci Rep. 2024; 14(1):29288.

PMID: 39592730 PMC: 11599766. DOI: 10.1038/s41598-024-80797-1.

Assessment of Erythrocyte Osmotic Fragility and Its Determinants, and Comparison of Hematological Indices Among Type 2 Diabetes Mellitus Patients on Follow-Up at Jimma Medical Center, Southwest Ethiopia.

Tujara Z, Reta W, Tadesse E, Dereje I, Tesfa M J Blood Med. 2024; 15:9-19.

PMID: 38283856 PMC: 10812138. DOI: 10.2147/JBM.S445620.

The correlation between peripheral complete blood count parameters and diabetic macular edema in proliferative diabetic retinopathy patients: a cross-sectional study.

Lei C, Gu J, Liu L, Zhang K, Zhang M Front Endocrinol (Lausanne). 2023; 14:1190239.

PMID: 37538792 PMC: 10395099. DOI: 10.3389/fendo.2023.1190239.

Associations of levels of peripheral blood leukocyte and subtypes with type 2 diabetes: A longitudinal study of Chinese government employees.

Li R, Li L, Liu B, Luo D, Xiao S Front Endocrinol (Lausanne). 2023; 14:1094022.

PMID: 37033252 PMC: 10080122. DOI: 10.3389/fendo.2023.1094022.

Acute kidney injury and diabetic kidney disease in children with acute complications of diabetes.

Soltysiak J, Krzysko-Pieczka I, Gertig-Kolasa A, Mularz E, Skowronska B, Ostalska-Nowicka D Pediatr Nephrol. 2022; 38(5):1643-1652.

PMID: 36227434 PMC: 10060302. DOI: 10.1007/s00467-022-05735-7.

References

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Kang E, Kim H, Ahn C, Park C, Cha B, Lim S . Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Res Clin Pract. 2005; 69(2):151-9. DOI: 10.1016/j.diabres.2004.11.014. View

Pecsvarady Z, Fisher T, Darwin C, Fabok A, Maqueda T, Saad M . Decreased polymorphonuclear leukocyte deformability in NIDDM. Diabetes Care. 1994; 17(1):57-63. DOI: 10.2337/diacare.17.1.57. View

Festa A, DAgostino Jr R, Howard G, Mykkanen L, Tracy R, Haffner S . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102(1):42-7. DOI: 10.1161/01.cir.102.1.42. View

Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. DOI: 10.1056/NEJM199901143400207. View

Avisar R, Friling R, Snir M, Avisar I, Weinberger D . Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. Isr Med Assoc J. 2007; 8(12):880-1. View

Esposito C, Gerlach H, Brett J, Stern D, Vlassara H . Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med. 1989; 170(4):1387-407. PMC: 2189465. DOI: 10.1084/jem.170.4.1387. View

Heidland A, Sebekova K, Schinzel R . Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis. 2001; 38(4 Suppl 1):S100-6. DOI: 10.1053/ajkd.2001.27414. View

Weijenberg M, Feskens E, Kromhout D . White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol. 1996; 16(4):499-503. DOI: 10.1161/01.atv.16.4.499. View

10.

Bo M, Massaia M, Raspo S, Bosco F, Cena P, Molaschi M . Predictive factors of in-hospital mortality in older patients admitted to a medical intensive care unit. J Am Geriatr Soc. 2003; 51(4):529-33. DOI: 10.1046/j.1532-5415.2003.51163.x. View

11.

Johnston S, Conner C, Aagren M, Smith D, Bouchard J, Brett J . Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2011; 34(5):1164-70. PMC: 3114512. DOI: 10.2337/dc10-1915. View

12.

Vlassara H, Fuh H, Donnelly T, Cybulsky M . Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med. 1995; 1(4):447-56. PMC: 2229997. View

13.

Stamler J, Vaccaro O, Neaton J, Wentworth D . Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16(2):434-44. DOI: 10.2337/diacare.16.2.434. View

14.

Cusumano A, Garcia-Garcia G, Di Gioia C, Hermida O, Lavorato C, Carreno C . End-stage renal disease and its treatment in Latin America in the twenty-first century. Ren Fail. 2006; 28(8):631-7. DOI: 10.1080/08860220600925693. View

15.

. Standards of medical care in diabetes--2011. Diabetes Care. 2011; 34 Suppl 1:S11-61. PMC: 3006050. DOI: 10.2337/dc11-S011. View

16.

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

17.

Tong P, Lee K, So W, Ng M, Chan W, Lo M . White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2003; 27(1):216-22. DOI: 10.2337/diacare.27.1.216. View

18.

Chung F, Tsai J, Chang D, Shin S, Lee Y . Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care. 2005; 28(7):1710-7. DOI: 10.2337/diacare.28.7.1710. View

19.

Stegenga M, van der Crabben S, Dessing M, Pater J, van den Pangaart P, de Vos A . Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med. 2008; 25(2):157-64. PMC: 2268957. DOI: 10.1111/j.1464-5491.2007.02348.x. View

20.

Vlassara H, Brownlee M, Manogue K, Dinarello C, Pasagian A . Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science. 1988; 240(4858):1546-8. DOI: 10.1126/science.3259727. View